GPATCH2L: A Potential Drug Target Or Biomarker (G55668)
GPATCH2L: A Potential Drug Target Or Biomarker
GPATCH2L (GPT2L_HUMAN), a protein found in human placenta, has been identified as a potential drug target or biomarker for various diseases. Its unique structure and function have drawn the attention of researchers, and its potential uses in drug development are being explored.
GPATCH2L is a single-chain protein that is expressed in various tissues of the body, including the placenta, brain, and heart. Its name comes from its structure, which is similar to that of a patch on a glove. It has a molecular weight of approximately 41 kDa and consists of 21 amino acid residues.
One of the unique features of GPATCH2L is its ability to interact with other proteins. It has been shown to interact with various proteins, including the transcription factor, NF-kappa-B, and the protein kinase. These interactions have important implications for its function in the body.
GPATCH2L has been shown to play a role in various biological processes, including fetal development, placenta function, and inflammation. Its role in fetal development is being explored as a potential drug target for diseases such as cancer, genetic disorders, and developmental disorders. For example, studies have shown that GPATCH2L is involved in the regulation of cell proliferation and has been shown to interact with proteins that are associated with cancer development.
GPATCH2L's role in placenta function is also being investigated as a potential drug target. The placenta plays a critical role in fetal development and is involved in the transfer of nutrients and oxygen from the mother to the baby. Studies have shown that GPATCH2L is involved in the regulation of placenta function and has been shown to interact with proteins that are associated with placenta dysfunction. This suggests that GPATCH2L may be a useful biomarker for monitoring placenta function and may have potential as a drug target for diseases such as placenta previa.
GPATCH2L's role in inflammation is also being explored as a potential drug target. Chronic inflammation is associated with a number of diseases, including heart disease and autoimmune disorders. Studies have shown that GPATCH2L is involved in the regulation of inflammation and has been shown to interact with proteins that are associated with inflammation. This suggests that GPATCH2L may be a useful target for drugs that are designed to reduce chronic inflammation.
In addition to its potential as a drug target, GPATCH2L has also been shown to have potential as a biomarker. Its unique structure and function make it an attractive candidate for use as a diagnostic protein. Studies have shown that GPATCH2L is expressed in various tissues of the body and has been shown to be stable in different conditions, including cancer and infection. This suggests that GPATCH2L may be a useful biomarker for monitoring disease and has potential as a diagnostic tool.
GPATCH2L's unique structure and function also make it an attractive candidate for use as a drug delivery system. Its small size and stability in various tissues make it a potential delivery system for small molecules and other drugs. Studies have shown that GPATCH2L is able to effectively deliver small molecules to specific tissues and has been shown to be effective in delivering drugs to the placenta. This suggests that GPATCH2L may be a useful delivery system for drugs that are designed to target specific tissues.
In conclusion, GPATCH2L is a protein that has unique structure and function and has the potential to be a drug target or biomarker for various diseases. Its interactions with other proteins and its role in various biological processes make it an attractive candidate for use as a potential drug target or biomarker. Its potential as a delivery system also makes it a promising candidate for these uses. Further research is needed to fully understand its potential uses and to determine its effectiveness as a drug target
Protein Name: G-patch Domain Containing 2 Like
The "GPATCH2L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPATCH2L comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
GPATCH3 | GPATCH4 | GPATCH8 | GPBAR1 | GPBP1 | GPBP1L1 | GPC1 | GPC1-AS1 | GPC2 | GPC3 | GPC4 | GPC5 | GPC5-AS1 | GPC5-AS2 | GPC6 | GPC6-AS1 | GPC6-AS2 | GPCPD1 | GPD1 | GPD1L | GPD2 | GPER1 | GPHA2 | GPHB5 | GPHN | GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52
